Trial intelligence / Profile preview

Hip-to-shoulder ratio and spread of spinal anesthesia in surgery patients

ACTRN12616000479404Phase 4Completed

Sponsor
Mehmet Canturk
Start
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of bupivacaine in inguinal hernia and arthropathy, sponsored by Mehmet Canturk. Primary endpoint: Effect of hip-to-shoulder ratio on cephalad spread of spinal anesthesia. Started Oct 2015; status: completed.

02

Drugs

bupivacaine
03

Conditions

inguinal herniaarthropathy

Beyond the preview

Go deeper on ACTRN12616000479404.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12616000479404.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call